Iovance Biotherapeutics Inc. (NASDAQ:IOVA) stock has declined by 29.92% in pre-market trading. This comes after the company reported its second-quarter financial results.Check out the current price of IOVA stock here. What Happened: The stock of the California-based biotechnology company was trad... Read more
Benzinga - Aug 08